CIK 0001553643 · Non-accelerated filer<br>Smaller reporting company
RELMADA THERAPEUTICS, INC.
Sign in to watch- Ticker
- RLMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 455401931
- Phone
- 646 876 3459
- Business address
- 2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, FL, 33134
- Former names
- CAMP NINE, INC.
- Open-market buys, last 90 days
- $1,671,990
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$1,671,990. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 78 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-17 | CASAMENTO CHARLES J Director | Option exercise · Options to purchase common stock | −10,000 | 102,500 | ||
| 2021-07-15 | CASAMENTO CHARLES J Director | Sale | −2,136 | $31.03 | $66K | 5,854 |
| 2021-07-15 | CASAMENTO CHARLES J Director | Sale | −1,164 | $32.49 | $38K | 4,700 |
| 2021-06-01 | CASAMENTO CHARLES J Director | Sale | −520 | $34.08 | $18K | 9,430 |
| 2021-06-01 | CASAMENTO CHARLES J Director | Sale | −2,480 | $33.19 | $82K | 6,950 |
| 2021-05-03 | CASAMENTO CHARLES J Director | Sale | −3,000 | $38.22 | $115K | 9,950 |
| 2021-04-01 | CASAMENTO CHARLES J Director | Sale | −1,309 | $35.93 | $47K | 14,641 |
| 2021-04-01 | CASAMENTO CHARLES J Director | Sale | −1,691 | $35.04 | $59K | 12,950 |
| 2021-03-10 | TRAVERSA SERGIO CEO | Sale | −2,983 | $35.09 | $105K | 88,774 |
| 2021-03-10 | Shenouda Maged CFO | Sale | −2,373 | $35.11 | $83K | 2,228 |
| 2021-03-09 | TRAVERSA SERGIO CEO | Option exercise | +10,000 | $3.24 | $32K | 98,774 |
| 2021-03-09 | TRAVERSA SERGIO CEO | Sale | −5,217 | $35.42 | $185K | 93,937 |
| 2021-03-09 | TRAVERSA SERGIO CEO | Sale | −1,800 | $36.32 | $65K | 91,757 |
| 2021-03-09 | TRAVERSA SERGIO CEO | Option exercise · Options to purchase common stock | −10,000 | 99,211 | ||
| 2021-03-09 | Kelly Paul Edward Director | Option exercise | +5,000 | $3.24 | $16K | 172,295 |
| 2021-03-09 | Kelly Paul Edward Director | Sale | −3,388 | $35.42 | $120K | 168,907 |
| 2021-03-09 | Kelly Paul Edward Director | Sale | −1,612 | $36.33 | $59K | 167,295 |
| 2021-03-09 | Kelly Paul Edward Director | Option exercise · Options to purchase common stock | −5,000 | 50,500 | ||
| 2021-03-09 | Shenouda Maged CFO | Sale | −5,727 | $35.42 | $203K | 6,401 |
| 2021-03-09 | Shenouda Maged CFO | Sale | −1,800 | $36.02 | $65K | 4,601 |
Page 8 of 9 · 178 trades